Department of Surgery, CUHK
INTRANET EVENTS NEWS


Dr CHONG Ching Ning Charing    
莊清寧

Clinical Professional Consultant
MBChB, MSc (Epidemiology and Biostatistics), FRCSEd (Gen), FHKAM (Surg)

Hepato-biliary and Pancreatic Surgery
(852) 3505 1496
chongcnadd this for spam@add this for spamsurgery.cuhk.edu.hk
M-3455-2018
0000-0002-8425-8767



Biography

Dr Chong is currently Clinical Professional Consultant in the Department of Surgery, Prince of Wales Hospital, the Chinese University of Hong Kong. She graduated from the Chinese University of Hong Kong and received her post-graduate surgical training mostly in the Prince of Wales Hospital in Hong Kong. She is a fellow of the Royal College of Surgeons of Edinburg and a member of several professional organizations including the International Hepato-Pancreato-Biliary Association (IHPBA), International Association of Surgeons, Gastroenterologists and Oncologists, Hong Kong Society of Hepatobiliary and Pancreatic Surgery, Hong Kong Society of Robotic Surgery and Asian EUS Group. She is also the honorary treasurer of Hong Kong Society of Hepatobiliary and Pancreatic Surgery.

After obtained her fellowship in 2010, she received her further training in surgical oncology at the Johns Hopkins Hospital and Robotic surgery in University of Illinois at Chicago. She also received her EUS training at Changhai Hospital in Shanghai and Asan Medical Center in Seoul.

She was specialized in general surgery (hepato-biliary and pancreatic surgery). Her main research interests are in the field of surgical management of hepato-biliary and pancreatic cancer. She is also interested in a number of hepato-biliary and pancreatic diseases, especially on interventional EUS and minimally invasive hepato-biliary and pancreatic surgery.


Research Interests

  • Multidisciplinary treatment for hepatobiliary and pancreatic cancer
  • Hepatitis-B virus related hepatocellular carcinoma
  • Minimally invasive and robotic surgery for hepatobiliary and pancreatic diseases
  • Advanced endoscopic endosonography
  • Pancreatic cystic disease


Additional Information

Positions in Professional Affiliations:

  • Council Member, Hong Kong Society of Hepatobiliary and Pancreatic Surgery
  • Member, Hong Kong Society of Minimal Access Surgery
  • Member, Hong Kong Society of Digestive Endoscopy
  • Member, Hong Kong Society of Robotic Surgery
  • Sub-committee of Standardization of Teaching Materials, Asian EUS Group

Positions in Peer-Reviewed Journal:
Reviewer for Journal of The American College of Surgeons, Journal of Gastroenterology and Hepatology, Liver International, HPB, Disease and Surgical Practice.


Selected Publications

  1. Chong CCN, Lakhtakia S, Nguyen N, Hara K, Chan WK, Puri R, Almadi MA, Ang TL, Kwek A, Yasuda I, Doi S, Kida M, Wang HP, Cheng TY, Jiang Q, Yang A, Chan AWH, Chan S, Tang R, Iwashita T, Teoh AYB. Endoscopic ultrasound-guided tissue acquisition with or without macroscopic on-site evaluation: randomized controlled trial. Endoscopy. 2020 Jun 4. doi: 10.1055/a-1172-6027. Online ahead of print.
  2. Chong CCN, Lee KF, Cheung SYS, Chu CCM, Fong AKW, Wong J, Hui JWY, Fung AKY, Lok HT, Lo EYJ, Chan SL, Yu SCH, Ng KKC, Lai PBS. Prospective double-blinded randomized controlled trial of Microwave versus RadioFrequency Ablation for hepatocellular carcinoma (McRFA trial). HPB (Oxford). 2020 Feb 8. pii:S1365-182X(20)30023-X. doi:10.1016/j.hpb.2020.01.008.
  3. Chong CCN, Lok HT, Fung AKY, Fong AKW, Cheung YS, Wong J, Lee KF, Lai PBS. Robotic versus laparoscopic hepatectomy: application of the difficulty scoring system. Surg Endosc. 2019 Jul 16. doi: 10.1007/s00464-019-06976-8.
  4. Chong CCN, Chung WY, Cheung YS, Fung AKY, Fong AKW, Lok HT, Wong J, Lee KF, Chan SKC, Lai PBS. Enhanced recovery after surgery for liver resection. Hong Kong Med J. 2019 Apr;25(2):94-101. doi: 10.12809/hkmj187656.
  5. Chong CC, Lee KF, Chu CM, Chan AW, Yu SC, Lai PB. Laparoscopic Hepatectomy(with or without Robotic Assistance) versus Radiofrequency Ablation as a Minimally Invasive Treatment for Very Early-Stage or Early-Stage Hepatocellular Carcinoma. Dig Surg. 2019 Mar 27:1-7. doi: 10.1159/000497112.
  6. Chong CCN, Lee KF, Chu CM, Chan AWH, Wong J, Chan SL, Lok HT, Fung AKY, Fong AKW, Cheung YS, Yu SCH, Johnson P, Lai PBS. Microwave ablation provides better survival than liver resection for hepatocellular carcinoma in patients with borderline liver function: application of ALBI score to patient selection. HPB (Oxford). 2018 Jun;20(6):546-554. doi: 10.1016/j.hpb.2017.12.001.
  7. Chong CC, Chan AW, Wong J, Chu CM, Chan SL, Lee KF, Yu SC, To KF, Johnson P, Lai PB. Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma. Surgeon. 2018 Jun;16(3):163-170. doi: 10.1016/j.surge.2017.07.003.
  8. Chong CCN, Teoh AYB, Tang RSY, Chan AWH, Ng EKW, Lai PBS. EUS-FNA using 22G nitinol or ProCore needles without on-site cytopathology. Endosc Ultrasound. 2018 Jan-Feb;7(1):56-60. doi: 10.4103/eus.eus_113_17.
  9. Chong CC, Wong GL, Chan AW, Wong VW, Fong AK, Cheung YS, Wong J, Lee KF, Chan SL, Lai PB, Chan HL. Liver stiffness measurement predicts high-grade post-hepatectomy liver failure: A prospective cohort study. J Gastroenterol Hepatol. 2017 Feb;32(2):506-514. doi: 10.1111/jgh.13503.
  10. Chong CC, Wong GL, Wong VW, Ip PC, Cheung YS, Wong J, Lee KF, Lai PB, Chan HL. Antiviral therapy improves post-hepatectomy survival in patients with hepatitis B virus-related hepatocellular carcinoma: a prospective-retrospective study. Aliment Pharmacol Ther. 2015 Jan;41(2):199-208. doi: 10.1111/apt.13034.



Copyright © 2021. All Rights Reserved. Department of Surgery, The Chinese University of Hong KongCUHK

C O N T A C T   U S